Power

Every day, a clinical trial is delayed due to recruitment planning issues. Often, it’s because recruitment planning came too late in the process. Today, we’re excited to share our latest white paper, Blueprint for Modern Patient Recruitment, which consolidates the top strategies sponsors are using to effectively plan and execute patient recruitment. We explore: 👉 How to quantify ROI on patient recruitment investments 👉 Fundamental shifts from a traditional to modern recruitment approach 👉 5 strategies top sponsors are using to modernize patient recruitment 👉 How to build a culture of patient centricity For industry professionals aiming to drive change and create more certainty in clinical trial recruitment, this white paper is not just a must-read but a roadmap to success. #ClinicalResearch #PatientRecruitment #ClinicalTrials #ClinicalTrialDiversity https://bit.ly/3IjykSp

🎙️ New Podcast Episode! In today’s episode of Power to the Patients, Srinivas Pai sits down with Katie Baca-Motes, Co-Founder at Scripps Research Digital Trial Center, to explore how clinical research can learn from other industries to improve patient experiences. Katie shares practical and thought-provoking insights, including: ✨ Designing trials that treat participants as true partners. ✨ Leveraging digital tools to make research accessible to everyone. ✨ Bringing lessons from Disney’s customer experience to clinical trials. ✨ Using behavioural science to reduce barriers and engage participants more effectively. This conversation dives into actionable ideas for rethinking how we approach clinical research. Don’t miss it! Links to the episode are in the comments below 👇 #ClinicalResearch #PatientCentricity

It's not a magic bullet, but it begins to crack the ice... This week’s episode takes a different angle: a perspective from the front lines of psychedelic patient care. I had the pleasure of sitting down with Manish Agrawal, CEO of Sunstone Therapies, to discuss his journey from oncology to leading groundbreaking work in psychedelic-assisted therapy. We explored the profound impact of these therapies, the challenges of integrating subjective patient experiences into research, and what the future of this field looks like. 🧠 Key takeaways:  - Why Manish left oncology to focus on the unmet emotional needs of patients. - The complexity of combining psychedelics with psychological support. - How subjective patient experiences challenge traditional clinical research methods. - Stories of life-changing patient transformations. - The evolving landscape of psychedelic therapies in mental health care. This conversation opened my eyes to what’s possible when we rethink patient care. Don’t miss it. Episode links in comments 👇 #podcast #psychedelics #clinicalresearch

Transforming mental health care means thinking beyond the lab – we must take a pragmatic approach for real-world application. This is the core message our co-CEO Srinivas Rao discussed with Brandon Li on the latest Power to the Patient podcast. At atai, we’re not just developing new therapies; we’re ensuring they can make a meaningful difference for patients and providers. New mental health treatments will only reach large-scale impact if they can be easily adopted by health systems and accessible to patients. That’s why a pragmatic, commercially-minded approach is core to what we do, as we explore the potential of psychedelic-based compounds to treat mental health disorders. In this episode, Srini and Brandon dive into: ▶️ Our focus on hard-to-treat conditions like treatment-resistant depression (TRD) and social anxiety disorder (SAD) ▶️ How we design treatments with the commercial end in mind – including innovative approaches to formulations, novel routes of administration and short treatment windows ▶️ The importance of balancing innovation with real-world applicability We’re proud to be at the forefront of this important work. Tune in to the full conversation below to hear how we’re keeping patients and providers at the heart of everything we do. Full episode here: https://lnkd.in/gaXJGSbp

Top 15 Neuropsychiatry Sites in Patient Responsiveness 🏆 These sites are doing incredible work in neuropsych patient recruitment. To create a list of the top 15 sites in Q3 2024, we looked at: 📅 total screening visits booked 🏥 % of qualified referrals with medical records booking a screening visit ⏱️ time to first outreach Congrats to these standout sites: Tandem Clinical Research, Patient Priority, North Texas Clinical Trials, Neurobehavioral Research, Renew Health Clinical Research, Sunwise Clinical Research, MSB Neuroscience, CenExel iResearch, Viking Clinical Research, IMA Clinical Research (Phoenix), Mountain View Clinical Research, Interventional Psychiatry of Tampa Bay, Floridian Neuroscience Institute, IMA Clinical Research (Las Vegas), Carilion Medical Center See what makes these sites stand out 👇 #clinicalresearch #patientrecruitment

New podcast episode with Srinivas Rao, Co-CEO of atai Life Sciences 🎧 #clinicalresearch #neuropsychiatry

Everything worth doing is probably hard right now… Excited to share my conversation with Srinivas Rao, Co-CEO of atai Life Sciences, where we explored the pragmatic strategies shaping the future of psychedelic therapies. We also delved into how atai is approaching drug development in areas with high unmet need like social anxiety disorder, TRD and cognitive impairment in schizophrenia. Srini's unique background in engineering and neuropharmacology offers a fascinating lens into how atai approaches drug development with pragmatism, and patient-centricity at its core. 🧠 Key highlights: - The evolution of atai Life Sciences, from a fund to a biotech company. - Innovative drug delivery approaches, like DMT oral thin films, and why simplicity and scalability matter. - Balancing diverse compounds and therapeutic areas with a focused portfolio strategy. - Advancing research in areas like social anxiety disorder and cognitive impairment in schizophrenia. - Tackling clinical trial challenges, including the placebo effect and trial design complexities. 🎧 Tune in to hear how Srini's pragmatic approach is redefining what’s possible in neuropsychiatric drug development. 👇 Links in comments #Neuropsychiatry #Psychedelics #DrugDevelopment #ClinicalResearch

Last week at the CNS Summit, I had the privilege of moderating a panel on patient trust in psychiatry trials with Kevin Craig, Michael Gold and Dan Karlin. Here are the most important takeaways from our discussion 👇 #CNSSummit2024

It’s not every day you leave a conference feeling like the momentum is unstoppable—but that’s exactly how CNS Summit felt for us. 🚀 Seeing people get excited about the mission behind withpower.com was inspiring. 👕 If you didn't get a chance to grab a t-shirt, we'd love to send you one. 👉 https://lnkd.in/g5x8DaWK To everyone we met at CNS, thank you for the conversations and the inspiration. If we didn’t connect this time, I’d love to keep the dialogue going. Always fun to catch up with old friends and new! Dawn Brockett, AMIR KALALI, MD, Michelle Longmire, Lauren Sunshine, Emily Epstein, LMSW, Joe Dustin, Megan Kelly, Steven T. Szabo, MD, PhD, Jaskaran (Jaz) Singh, Jose Contreras, Heather Sutton, Kabir Nath, Srinivas Rao, Maggie Gordon, Alexandra Dosen, Leah Moore (Getchell), Atul Mahableshwarkar, Timo Taghizadeh, Hugo Vimal, Emily Scullin, Morgan Touey Rinnier, Jessica (Jess) Potestivo, Jennylyn Trainor, Katie Rodammer, M.H.A., Justin Goodarz, Mitchell Efros, Kelly Calistri, Karma Hamilton, Jessica Griffiths, Ni Khin, Leah Aluisio, Susanna Chang, Anthony Duong, Reuben F. #CNSSummit2024

"Clinical trial participants should be national heroes" Kevin Craig, Michael Gold and Dan Karlin joined me to discuss building patient trust in clinical trials at CNS Summit A few salient points stood out: 1. Trust in pharma is at an all time low. While we can't do anything about misaligned incentives, there is plenty that sponsors and sites can be intentional about. 2. It starts with honesty. Especially given the hype in psychedelic research, it's important to be clear about expectations. One site we spoke with has even transitioned to calling patients "volunteers". 3. Patient recruitment is the tip of the spear. This starts with response rates and flows through to how medical information is collected, shared, and protected 4. The site experience drives so much. First impressions at a clinic from the waiting room to staff organization can put patients at ease or on edge Had a blast moderating this panel and can't wait to reconnect with the CNS community next year